(Reuters) – The government of Australia has signed an advanced agreement to purchase 51 million doses of Novavax Inc’s experimental COVID-19 vaccine, the company disclosed in a regulatory filing on Thursday.
(Reuters) – The government of Australia has signed an advanced agreement to purchase 51 million doses of Novavax Inc’s experimental COVID-19 vaccine, the company disclosed in a regulatory filing on Thursday.
